SE8305916L - INTERMEDIATES FOR PENICILLANIC ACID-1,1-Dioxide PREPARATION - Google Patents

INTERMEDIATES FOR PENICILLANIC ACID-1,1-Dioxide PREPARATION

Info

Publication number
SE8305916L
SE8305916L SE8305916A SE8305916A SE8305916L SE 8305916 L SE8305916 L SE 8305916L SE 8305916 A SE8305916 A SE 8305916A SE 8305916 A SE8305916 A SE 8305916A SE 8305916 L SE8305916 L SE 8305916L
Authority
SE
Sweden
Prior art keywords
penicillanic acid
esters
intermediates
dioxide
dioxides
Prior art date
Application number
SE8305916A
Other languages
Swedish (sv)
Other versions
SE8305916D0 (en
SE447995B (en
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8305916(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SE8305916L publication Critical patent/SE8305916L/en
Publication of SE8305916D0 publication Critical patent/SE8305916D0/en
Publication of SE447995B publication Critical patent/SE447995B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1,1-Dioxides of penicillanic acid and esters are described which are useful as beta -lactamase inhibitors. These compounds are 1,1-dioxides of penicillanic acid and of corresponding esters which are easily hydrolysable in vivo, derivatives of penicillanic acid 1,1-dioxide, the carboxyl radical of which is protected by a standard protective group of the carboxyl radical of penicillins, which are useful intermediates for the synthesis of penicillanic acid 1,1-dioxide, and 1-oxides of penicillanic acid and of certain of its esters which are useful as chemical intermediates for the synthesis of penicillanic acid 1,1-dioxide and of its esters. These 1,1-dioxides of penicillanic acid and esters are antibacterial agents, also capable of increasing the effectiveness of various antibiotics of the beta -lactam type with respect to bacteria which produce beta -lactamase.
SE8305916A 1977-06-07 1983-10-27 INTERMEDIATE FOR PREPARATION OF PENCILLANIC ACID-1,1-DIOXIDES SE447995B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (3)

Publication Number Publication Date
SE8305916L true SE8305916L (en) 1983-10-27
SE8305916D0 SE8305916D0 (en) 1983-10-27
SE447995B SE447995B (en) 1987-01-12

Family

ID=27122691

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7806628A SE436206B (en) 1977-06-07 1978-06-06 PENICILLANIC ACID-1,1-DIOXIDES WITH ANTIBACTERIAL EFFECTS
SE8305916A SE447995B (en) 1977-06-07 1983-10-27 INTERMEDIATE FOR PREPARATION OF PENCILLANIC ACID-1,1-DIOXIDES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7806628A SE436206B (en) 1977-06-07 1978-06-06 PENICILLANIC ACID-1,1-DIOXIDES WITH ANTIBACTERIAL EFFECTS

Country Status (35)

Country Link
AR (1) AR224111A1 (en)
AT (2) AT360649B (en)
AU (1) AU513636B2 (en)
BE (1) BE867859A (en)
BG (2) BG34615A3 (en)
CH (1) CH634073A5 (en)
CS (1) CS208472B2 (en)
DD (2) DD148585A5 (en)
DE (2) DE2857263C3 (en)
DK (1) DK155740C (en)
EG (1) EG13869A (en)
FI (1) FI66003C (en)
FR (2) FR2393804A1 (en)
GB (1) GB2000138B (en)
GR (1) GR72255B (en)
HK (1) HK13184A (en)
HU (1) HU180042B (en)
IE (1) IE47079B1 (en)
IL (2) IL54867A (en)
IN (1) IN149747B (en)
IT (1) IT1096381B (en)
KE (1) KE3355A (en)
LU (1) LU79774A1 (en)
MY (1) MY8500092A (en)
NL (2) NL180009C (en)
NO (2) NO151746C (en)
NZ (1) NZ187476A (en)
OA (1) OA05964A (en)
PH (3) PH26810A (en)
PL (1) PL114501B1 (en)
PT (1) PT68146A (en)
SE (2) SE436206B (en)
SG (1) SG65383G (en)
SU (1) SU860706A1 (en)
YU (1) YU41829B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (en) * 1977-05-09 1979-01-18
DE2912511C2 (en) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmaceutical composition containing penicillanic acid
DK155942C (en) * 1977-12-23 1989-10-23 Pfizer METHOD OF ANALOGUE FOR THE PREPARATION OF 6-AMINOPENICILLANIC ACID-1,1-DIOXIDE AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION AND BASIS SALTS.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (en) * 1979-03-05 1987-04-06 Pfizer SET TO PENICILLANIC ACID-1,1-DIOXIDE AND ESSERS THEREOF
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (en) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (en) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd METHOD FOR PRODUCING PENICILLANIC ACID DERIVATIVES.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (en) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 Method for preparing and crystallizing sulbactam pivoxyl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (en) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DK155740B (en) 1989-05-08
FI66003C (en) 1984-08-10
IE47079B1 (en) 1983-12-14
NZ187476A (en) 1982-08-17
BG34614A3 (en) 1983-10-15
FR2393805B1 (en) 1984-02-24
IT1096381B (en) 1985-08-26
FR2393804B1 (en) 1980-11-07
SE7806628L (en) 1978-12-08
FI781800A (en) 1978-12-08
OA05964A (en) 1981-06-30
YU117078A (en) 1983-01-21
SE8305916D0 (en) 1983-10-27
DE2824535C3 (en) 1981-01-22
NL930064I1 (en) 1993-09-01
FR2393804A1 (en) 1979-01-05
PH26810A (en) 1992-11-05
NO781970L (en) 1978-12-08
PL114501B1 (en) 1981-02-28
PL207396A1 (en) 1979-06-04
DE2857263C3 (en) 1981-12-17
AU3683878A (en) 1979-12-06
SG65383G (en) 1985-03-29
BE867859A (en) 1978-12-06
DD140888A5 (en) 1980-04-02
IL54867A (en) 1981-11-30
IL62168A0 (en) 1981-03-31
CH634073A5 (en) 1983-01-14
IN149747B (en) 1982-04-03
IT7824270A0 (en) 1978-06-06
NL930064I2 (en) 1994-04-18
IE781140L (en) 1978-12-07
ATA128580A (en) 1981-02-15
SU860706A1 (en) 1981-08-30
AU513636B2 (en) 1980-12-11
HU180042B (en) 1983-01-28
DK155740C (en) 1989-10-23
MY8500092A (en) 1985-12-31
HK13184A (en) 1984-02-24
SE447995B (en) 1987-01-12
PT68146A (en) 1978-07-01
NO152448C (en) 1985-10-02
SE436206B (en) 1984-11-19
BG34615A3 (en) 1983-10-15
NL7806126A (en) 1978-12-11
GB2000138A (en) 1979-01-04
PH21116A (en) 1987-07-16
ATA411278A (en) 1980-06-15
DD148585A5 (en) 1981-06-03
EG13869A (en) 1983-03-31
DK251478A (en) 1978-12-08
FR2393805A1 (en) 1979-01-05
AR224111A1 (en) 1981-10-30
GB2000138B (en) 1982-03-03
DE2824535A1 (en) 1978-12-14
KE3355A (en) 1983-12-16
NO152448B (en) 1985-06-24
AT364084B (en) 1981-09-25
GR72255B (en) 1983-10-06
AT360649B (en) 1981-01-26
PH16465A (en) 1983-10-20
NO823126L (en) 1978-12-08
CS208472B2 (en) 1981-09-15
IL54867A0 (en) 1978-08-31
NO151746B (en) 1985-02-18
DE2857263B2 (en) 1981-04-23
LU79774A1 (en) 1980-01-22
YU41829B (en) 1988-02-29
FI66003B (en) 1984-04-30
NL180009C (en) 1986-12-16
NO151746C (en) 1985-06-05
DE2824535B2 (en) 1980-05-14

Similar Documents

Publication Publication Date Title
SE8305916L (en) INTERMEDIATES FOR PENICILLANIC ACID-1,1-Dioxide PREPARATION
SE8003603L (en) BIS-ESTERS OF METANTHIOL WITH PENICILLINES AND PENICILLANIC ACID-1,1-DIOXIDE
IE850293L (en) Penicillin compounds
IE43840L (en) Clavulanic acid derivatives
ES2129397T3 (en) HETEROAROIL DERIVATIVES OF MONOCYCLE BETA-LACTAM ANTIBIOTICS.
SE8500965D0 (en) INTERMEDIATES FOR THE PREPARATION OF BETA-LACTAMA INHIBITORS
ES8305769A1 (en) Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide and beta-lactam antibiotics.
SE8603309D0 (en) INTERMEDIATES FOR PENICILLANIC ACID-1,1-DIOXIDE PREPARATION AND ESTERS THEREOF
ATE14585T1 (en) BETA-LACTAMASE INHIBITORS 2-BETA-SUBSTITUTED 2ALPHA-METHYL-(5R)-PENAM-3-ALPHA-CARBONIC-1,1-DIOXIDES AND INTERMEDIATE PRODUCTS.
ES455404A1 (en) Therapeutic compounds containing beta -lactams
SE7709736L (en) OXADETIA-CEPHALOSPORINER
SE7709071L (en) OLIVANIC ACID ESTERS
ES476259A1 (en) Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them.
ES8204436A1 (en) Chemical compound
FI812312L (en) ETT NYTT FOERFARANDE FOER FRAMSTAELLNING AV 6-AMINOPENICILLANSYRA-1,1-DIOXID
KR900005050B1 (en) 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof
ES423024A1 (en) Novel acid compounds
ES469922A1 (en) A procedure for the preparation of a derivative of penicilanic acid 1,1-dioxide (Machine-translation by Google Translate, not legally binding)
GB1057028A (en) New penicillins
GB1405793A (en) Thioacetyl penicillins and cephalosporins
GB1053818A (en)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305916-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305916-2

Format of ref document f/p: F